• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)和严重急性呼吸综合征冠状病毒(SARS-CoV)与人血管紧张素转换酶2(ACE2)的结合:确定结合位点及其对ACE2刚性的影响

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness.

作者信息

Faisal H M Nasrullah, Katti Kalpana S, Katti Dinesh R

机构信息

Department of Civil, Construction and Environmental Engineering, North Dakota State University, Fargo, ND 58108, United States.

Center for Engineered Cancer Testbeds, North Dakota State University, Fargo, ND 58108, United States.

出版信息

Chem Phys. 2021 Nov 1;551:111353. doi: 10.1016/j.chemphys.2021.111353. Epub 2021 Sep 6.

DOI:10.1016/j.chemphys.2021.111353
PMID:34511698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8420131/
Abstract

The SARS-CoV-2 coronavirus (COVID-19) that is causing the massive global pandemic exhibits similar human cell invasion mechanism as the coronavirus SARS-CoV, which had significantly lower fatalities. The cell membrane protein Angiotensin-converting enzyme 2 (ACE2) is the initiation point for both the coronavirus infections in humans. Here, we model the molecular interactions and mechanical properties of ACE2 with both SARS-CoV and COVID-19 spike protein receptor-binding domains (RBD). We report that the COVID-19 spike RBD interacts with ACE2 more strongly and at only two protein residues, as compared to multi-residue interaction of the SARS-CoV. Although both coronaviruses stiffen the ACE2, the impact of COVID-19 is six times larger, which points towards differences in the severity of the reported respiratory distress. The recognition of specific residues of ACE2 attachments to coronaviruses is important as the residues suggest potential sites of intervention to inhibit attachment and subsequent entry of the COVID-19 into human host cells.

摘要

引发全球大规模疫情的严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)展现出了与致死率低得多的冠状病毒SARS-CoV相似的入侵人体细胞机制。细胞膜蛋白血管紧张素转换酶2(ACE2)是这两种冠状病毒感染人类的起始点。在此,我们对ACE2与SARS-CoV和新冠病毒刺突蛋白受体结合域(RBD)的分子相互作用及力学性质进行建模。我们报告称,与SARS-CoV的多残基相互作用相比,新冠病毒刺突RBD与ACE2的相互作用更强,且仅涉及两个蛋白质残基。尽管两种冠状病毒都会使ACE2变硬,但新冠病毒的影响要大六倍,这表明了所报告的呼吸窘迫严重程度存在差异。识别ACE2与冠状病毒结合的特定残基很重要,因为这些残基提示了抑制新冠病毒附着及随后进入人类宿主细胞的潜在干预位点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/bef3a6776ad1/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/4022e46ea0fe/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/9169fae996a6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/ce3b10771f8a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/4ec9a1b847bb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/e1e546a460cb/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/41d55ba4f0eb/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/174a76483a2d/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/2a9449e930d5/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/bef3a6776ad1/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/4022e46ea0fe/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/9169fae996a6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/ce3b10771f8a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/4ec9a1b847bb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/e1e546a460cb/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/41d55ba4f0eb/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/174a76483a2d/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/2a9449e930d5/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86a/8420131/bef3a6776ad1/gr8_lrg.jpg

相似文献

1
Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness.严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)和严重急性呼吸综合征冠状病毒(SARS-CoV)与人血管紧张素转换酶2(ACE2)的结合:确定结合位点及其对ACE2刚性的影响
Chem Phys. 2021 Nov 1;551:111353. doi: 10.1016/j.chemphys.2021.111353. Epub 2021 Sep 6.
2
Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.SARS-CoV-2 刺突 RBD 与人 ACE2 蛋白-蛋白相互作用的生物力学特性分析。
Biophys J. 2021 Mar 16;120(6):1011-1019. doi: 10.1016/j.bpj.2021.02.007. Epub 2021 Feb 17.
3
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的抑制剂筛选及其阻断病毒进入机制的能力:一项病毒信息学研究。
Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26.
4
Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.探究 SARS-CoV-2 P.1 变体刺突蛋白与人 ACE2 受体增强结合的结构基础。
J Cell Biochem. 2022 Jul;123(7):1207-1221. doi: 10.1002/jcb.30276. Epub 2022 May 27.
5
Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.突变对人 SARS-CoV-2 受体结合域与宿主细胞受体 ACE2 结构、功能和动力学的影响:分子动力学模拟研究。
J Biomol Struct Dyn. 2021 Nov;39(18):7231-7245. doi: 10.1080/07391102.2020.1802348. Epub 2020 Aug 7.
6
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.SARS-CoV-2 刺突蛋白与人 ACE2 受体相互作用的蛋白质结构分析:从构象变化到新型中和抗体。
Cell Mol Life Sci. 2021 Feb;78(4):1501-1522. doi: 10.1007/s00018-020-03580-1. Epub 2020 Jul 4.
7
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.SARS-CoV-2 刺突受体结合域的突变景观和计算机结构模型揭示了病毒-宿主相互作用的关键分子决定因素。
BMC Mol Cell Biol. 2022 Jan 7;23(1):2. doi: 10.1186/s12860-021-00403-4.
8
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明,大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
9
Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.介导与ACE2相互作用的新冠病毒刺突蛋白受体结合域关键残基:一项分子动力学研究
Nanoscale. 2021 May 27;13(20):9364-9370. doi: 10.1039/d1nr01672e.
10
Structure-Based Development of SARS-CoV-2 Spike Interactors.基于结构的 SARS-CoV-2 刺突相互作用蛋白开发。
Int J Mol Sci. 2022 May 17;23(10):5601. doi: 10.3390/ijms23105601.

引用本文的文献

1
Integrating Chemo- and Bioinformatics with Biological Assays to Discover Potential ACE2 and Mpro Inhibitors against SARS-CoV-2.将化学信息学和生物信息学与生物学检测相结合,以发现针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜在血管紧张素转换酶2(ACE2)和主要蛋白酶(Mpro)抑制剂。
J Chem Inf Model. 2025 Aug 11;65(15):8249-8261. doi: 10.1021/acs.jcim.5c01056. Epub 2025 Jul 25.
2
Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base.席夫碱的合成、表征、计算分析、计算机辅助ADMET研究以及对严重急性呼吸综合征冠状病毒2型主要蛋白酶(Mpro)的抑制作用
Turk J Chem. 2022 Jun 2;46(5):1548-1564. doi: 10.55730/1300-0527.3460. eCollection 2022.
3

本文引用的文献

1
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020.在中国武汉2019 - 2020年肺炎病例群中发现的一种新型冠状病毒基因组
China CDC Wkly. 2020 Jan 24;2(4):61-62.
2
Differences in Interactions Within Viral Replication Complexes of SARS-CoV-2 (COVID-19) and SARS-CoV Coronaviruses Control RNA Replication Ability.严重急性呼吸综合征冠状病毒2(COVID-19)和严重急性呼吸综合征冠状病毒的病毒复制复合物内相互作用的差异控制RNA复制能力。
JOM (1989). 2021;73(6):1684-1695. doi: 10.1007/s11837-021-04662-6. Epub 2021 Apr 22.
3
Dissociation Mechanisms of G-actin Subunits Govern Deformation Response of Actin Filament.
Severe COVID-19-A Review of Suggested Mechanisms Based on the Role of Extracellular Matrix Stiffness.
严重 COVID-19-基于细胞外基质硬度作用的建议机制综述。
Int J Mol Sci. 2023 Jan 7;24(2):1187. doi: 10.3390/ijms24021187.
4
Molecular and structural basis of actin filament severing by ADF/cofilin.肌动蛋白解聚因子/丝切蛋白切断肌动蛋白丝的分子和结构基础。
Comput Struct Biotechnol J. 2022 Aug 4;20:4157-4171. doi: 10.1016/j.csbj.2022.07.054. eCollection 2022.
5
Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2.从羟氯喹和 1,2,4,5-四氧杂环己烷类似物中鉴定出潜在的抗病毒抑制剂,并研究其在 SARS-CoV-2 中的作用机制。
Int J Mol Sci. 2022 Feb 4;23(3):1781. doi: 10.3390/ijms23031781.
G- 肌动蛋白亚基的解离机制控制肌动蛋白丝的变形响应。
Biomacromolecules. 2021 Feb 8;22(2):907-917. doi: 10.1021/acs.biomac.0c01602. Epub 2021 Jan 22.
4
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
5
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.血管紧张素转化酶 2(ACE2)在 COVID-19 中的作用。
Crit Care. 2020 Jul 13;24(1):422. doi: 10.1186/s13054-020-03120-0.
6
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.新型冠状病毒病 2019 的肺损伤和心血管并发症的病理生理特征和治疗方法。
Cardiovasc Pathol. 2020 Jul-Aug;47:107228. doi: 10.1016/j.carpath.2020.107228. Epub 2020 Apr 17.
7
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.SARS-CoV-2 刺突受体结合域与 ACE2 受体复合物的结构。
Nature. 2020 May;581(7807):215-220. doi: 10.1038/s41586-020-2180-5. Epub 2020 Mar 30.
8
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
9
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.